URI
53
-2
HRB
51
2
GM
65
-3
CMCSA
48
2
MCO
73
3
PSA
51
-4
HP
38
-2
BMY
53
-7
PBI
60
-5
BBY
40
3
HCP
58
4
OXY
40
3
DTE
50
3
HON
65
-2
ACN
47
-2
ALLE
37
5
MRO
55
3
UHS
54
3
XYL
37
2
CAG
30
4
URI
53
-2
HRB
51
2
GM
65
-3
CMCSA
48
2
MCO
73
3
PSA
51
-4
HP
38
-2
BMY
53
-7
PBI
60
-5
BBY
40
3
HCP
58
4
OXY
40
3
DTE
50
3
HON
65
-2
ACN
47
-2
ALLE
37
5
MRO
55
3
UHS
54
3
XYL
37
2
CAG
30
4
Financhill
Back

Dianthus Therapeutics Vs. Cartesian Therapeutics Industry Stock Comparison

Sell
1

DNTH
Dianthus Therapeutics

Last Price:
20.87
Seasonality Move:
12.89%
Sell
26

RNAC
Cartesian Therapeutics

Last Price:
16.93
Seasonality Move:
13.13%
Sell
1
Dianthus Therapeutics (DNTH) is a Sell

Is Dianthus Therapeutics a Buy, Sell or Hold?

  • The current Dianthus Therapeutics [DNTH] share price is $20.77. The Score for DNTH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • DNTH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DNTH Stock Price Chart

What is Dianthus Therapeutics's stock price today?

  • The Dianthus Therapeutics share price today is $20.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNTH is experiencing selling pressure, which indicates risk of future bearish movement.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $16.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.

DNTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.34 Sell
Relative Strength Index (14 RSI): 23.86 Sell
Chaikin Money Flow: -146216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.88 - 29.38) Sell
Bollinger Bands (100): (26.17 - 29.09) Sell

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.75 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: -99129 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.09 - 22.05) Sell
Bollinger Bands (100): (14.31 - 20.45) Sell

DNTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.66 Sell
20-day SMA: 26.9 Sell
50-day SMA: 27.25 Sell
200-day SMA: 26.2 Sell
8-day EMA: 24.1 Sell
20-day EMA: 26.01 Sell
50-day EMA: 26.96 Sell
200-day EMA: 24.96 Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.66 Sell
20-day SMA: 19.51 Sell
50-day SMA: 19.31 Sell
200-day SMA: 20 Sell
8-day EMA: 17.92 Sell
20-day EMA: 18.95 Sell
50-day EMA: 19.03 Sell
200-day EMA: 21.01 Sell

Dianthus Therapeutics Earnings Growth & DNTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

Dianthus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):